EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease

Siriwan Sakarin, Anudep Rungsipipat, Sittiruk Roytrakul iD, Janthima Jaresitthikunchai, Narumon Phaonakrop, Sawanya Charoenlappanit iD, Siriwan Thaisakun, Sirilak Surachetpong

PeerJ · 2024

DOI: 10.7717/peerj.17186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Siriwan Sakarin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand, Bangkok, Thailand. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Proteomics, Phosphoproteins, Dog Diseases. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund), 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH), a common complication in dogs affected by degenerative mitral valve disease (DMVD), is a progressive disorder characterized by increased pulmonary arterial pressure (PAP) and pulmonary vascular remodeling. Phosphorylation of proteins, impacting vascular function and cell proliferation, might play a role in the development and progression of PH. Unlike gene or protein studies, phosphoproteomic focuses on active proteins that function as end-target proteins within signaling cascades. Studying phosphorylated proteins can reveal active contributors to PH development. Early diagnosis of PH is crucial for effective management and improved clinical outcomes. This study aimed to identify potential serum biomarkers for diagnosing PH in dogs affected with DMVD using a phosphoproteomic approach. Serum samples were collected from healthy control dogs ( n = 28), dogs with DMVD ( n = 24), and dogs with DMVD and PH ( n = 29). Phosphoproteins were enriched from the serum samples and analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Data analysis was performed to identify uniquely expressed phosphoproteins in each group and differentially expressed phosphoproteins among groups. Phosphoproteomic analysis revealed nine uniquely expressed phosphoproteins in the serum of dogs in the DMVD+PH group and 15 differentially upregulated phosphoproteins in the DMVD+PH group compared to the DMVD group. The phosphoproteins previously implicated in PH and associated with pulmonary arterial remodeling, including small nuclear ribonucleoprotein G (SNRPG), alpha-2-macroglobulin (A2M), zinc finger and BTB domain containing 42 (ZBTB42), hemopexin (HPX), serotransferrin (TRF) and complement C3 (C3), were focused on. Their unique expression and differential upregulation in the serum of DMVD dogs with PH suggest their potential as biomarkers for PH diagnosis. In conclusion, this phosphoproteomic study identified uniquely expressed and differentially upregulated phosphoproteins in the serum of DMVD dogs with PH. Further studies are warranted to validate the diagnostic utility of these phosphoproteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryProteomicsPhosphoproteinsDog DiseasesBiomarkersAnimalsDogsTandem Mass SpectrometryMaleHeart Valve DiseasesFemaleMitral ValveChromatography, Liquid

Stichwörter der Autor:innen

BiomarkersDegenerative mitral valve diseaseDogsPhosphoproteomicsProteomicsPulmonary hypertensionSerum

Substanzen

PhosphoproteinsBiomarkers

Autor:innen und Institutionen

  • Department of Veterinary Medicine, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand, Bangkok, Thailand.
  • Center of Excellence for Companion Animal Cancer, Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand, Bangkok, Thailand.
  • Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, Thailand, Bangkok, Thailand.

ORCID-Profile: Sittiruk Roytrakul, Sawanya Charoenlappanit

Förderung

  • 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)
  • 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship

Zitieren

APA

Sakarin, S., Rungsipipat, A., Roytrakul, S., Jaresitthikunchai, J., Phaonakrop, N., Charoenlappanit, S., Thaisakun, S., & Surachetpong, S. (2024). Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease. PeerJ. https://doi.org/10.7717/peerj.17186

Vancouver

Sakarin S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, Charoenlappanit S, et al. Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease. PeerJ. 2024. doi:10.7717/peerj.17186

BibTeX
@article{Sakarin2024,
  author = {Sakarin, Siriwan and Rungsipipat, Anudep and Roytrakul, Sittiruk and Jaresitthikunchai, Janthima and Phaonakrop, Narumon and Charoenlappanit, Sawanya and Thaisakun, Siriwan and Surachetpong, Sirilak},
  title = {Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.17186}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche